Sterling Investment Advisors (Pennsylvania)’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,000
Closed -$11K 192
2022
Q2
$11K Buy
6,000
+3,000
+100% +$6.48K ﹤0.01% 391
2022
Q1
$10K Hold
3,000
﹤0.01% 427
2021
Q4
$13K Hold
3,000
﹤0.01% 413
2021
Q3
$18K Buy
+3,000
New +$20.1K 0.01% 369
2021
Q1
Sell
-1,050
Closed -$13K 512
2020
Q4
$13K Hold
1,050
﹤0.01% 343
2020
Q3
$17K Sell
1,050
-1,000
-49% -$16.4K 0.01% 307
2020
Q2
$30K Buy
2,050
+50
+3% +$675 0.01% 259
2020
Q1
$14K Hold
2,000
0.01% 295
2019
Q4
$11K Hold
2,000
0.01% 333
2019
Q3
$8K Sell
2,000
-1,000
-33% -$3.74K ﹤0.01% 353
2019
Q2
$12K Hold
3,000
0.01% 334
2019
Q1
$12K Buy
3,000
+2,000
+200% +$6.86K 0.01% 327
2018
Q4
$2K Hold
1,000
﹤0.01% 376
2018
Q3
$4K Hold
1,000
﹤0.01% 388
2018
Q2
$3K Hold
1,000
﹤0.01% 362
2018
Q1
$4K Buy
+1,000
New +$3.37K ﹤0.01% 339

Other funds holding CGEN

Sterling Investment Advisors (Pennsylvania)'s CGEN Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Compugen (CGEN) in Q3 2022, closing a stake of 6,000 shares — an estimated $11K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in CGEN in Q1 2018 and held it in 16 quarters. The position peaked at $30K in Q2 2020. 81 funds tracked by Wall St. Rank hold CGEN as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Compugen position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 6,000 Compugen shares in Q3 2022, an estimated $11K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Compugen in Q1 2018 and held it in 16 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Compugen position peaked at $30K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Compugen as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.